who should not take semaglutide Weight loss & Ozempic have become synonymous terms! Aside from becoming an absolute game changer in type two diabetic management, semaglutide's ability to assist with weight management has changed the future of Why Am I Not Losing

In Alzheimers, the brain struggles to use this sugar properly

Research in people with Type 2 diabetes has shown that GLP-1 receptor agonists may lower the chances of having a heart attack, stroke, or dying from cardiovascular (heart and blood vessel) problems

For patients managing both conditions, the weight loss dosing approach needs to balance glycemic control with fat reduction goals

Researchers theorize this may be because: GIP activation may counterbalance some GLP-1 effects on the gut Dose escalation schedule allows more gradual adaptation Different pharmacokinetic profile may produce less pronounced peaks Serious Side Effects (Both Medications): These are rare but require immediate medical attention: Pancreatitis: Severe abdominal pain that may radiate to the back Risk: Less than 1% with both medications Usually occurs in first few months of treatment Requires immediate discontinuation if suspected Gallbladder Problems: Gallstones, cholecystitis (gallbladder inflammation) Symptoms: Right upper abdominal pain, nausea, fever More common with rapid weight loss May require surgical intervention Kidney Problems: Dehydration from vomiting/diarrhea can affect kidney function Watch for decreased urination, swelling in legs Stay well-hydrated, especially during side effect periods Thyroid Tumors (Black Box Warning): Both medications carry warnings about thyroid C-cell tumors Based on rodent studies

For personalized medical advice and convenient care, Doctronic.ai offers an innovative solution combining AI expertise with human doctors available 24/7

10.1016/j.taap.2017.07.010 91 GawandeD